Cancer drugs - updates

Rappler's latest stories on Cancer drugs


New breast cancer drug found to boost survival rates by 30%

Jun 02, 2019 - 3:10 PM

The drug, marketed under the brand name Kisqali, costs $12,553 for a 28-day dose, says Jamie Bennett, a spokeswoman for Novartis, which marketed and funded research

AstraZeneca, Merck strike key cancer drugs partnership

Jul 27, 2017 - 4:32 PM

The strategic collaboration is expected to further increase the number of treatment options available to patients British company AstraZeneca and its US peer Merck say in a statement

Sanofi makes $9.3B offer for cancer drug firm Medivation

Apr 28, 2016 - 7:40 PM

If the bid is accepted it would be Sanofi s biggest acquisition since its 20B purchase of Genzyme in 2011

epa05139690 (FILE) A file photo dated 25 September 2012 showing a general view of the drug manufacturer Sanofi's office in Paris, France. Sanofi, France's largest drugmaker, said 02 February 2016 that it has launched a research project to develop a vaccine to combat the Zika virus. There is currently no vaccine against the Zika virus or specific treatment for the infection it causes. Zika is a mosquito-borne virus similar to dengue, against which Sanofi Pasteur - the vaccine division of French pharmaceutical company Sanofi - recently marketed the first vaccine. EPA/YOAN VALAT

Drug helps breast cancer patients preserve fertility

May 31, 2014 - 8:23 AM

The drug goserelin is shown to improve survival and fertility among breast cancer patients

CANCER UP CLOSE. A scanned image of a breast carcinoma tissue stained to test for the presence of abnormal copies of the HER2 gene, viewed at 40x magnification. Quintiles Transnational handout/EPA/14 Sept 2009

Scientists cast doubt on Alzheimer's 'cure'

May 26, 2013 - 4:05 PM

Four separate teams of scientists have said they were unable to replicate a highly publicized study that last year touted a cancer drug s success against Alzheimer s disease in mice